Table 1. Peptide CDMO Pharmaceutical Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Peptide CDMO Pharmaceutical Market Restraints

Table 3. Peptide CDMO Pharmaceutical Market Trends

Table 4. Peptide CDMO Pharmaceutical Industry Policy

Table 5. Global Peptide CDMO Pharmaceutical Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Peptide CDMO Pharmaceutical Revenue Share by Company, 2019-2024, Ranked by Data of 2022

Table 7. Global Peptide CDMO Pharmaceutical Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Peptide CDMO Pharmaceutical Mergers & Acquisitions, Expansion Plans

Table 9. Global Peptide CDMO Pharmaceutical Major Companies Product Type

Table 10. Head Office and Area Served of Key Players

Table 11. China Peptide CDMO Pharmaceutical Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022

Table 12. China Peptide CDMO Pharmaceutical Revenue Market Share by Company, 2019-2024

Table 13. Global Key Players of Peptide CDMO Pharmaceutical Upstream (Raw Materials)

Table 14. Global Peptide CDMO Pharmaceutical Typical Customers

Table 15. Peptide CDMO Pharmaceutical Typical Distributors

Table 16. By Type, Global Peptide CDMO Pharmaceutical Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 17. By Application, Global Peptide CDMO Pharmaceutical Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 18. By Region, Global Peptide CDMO Pharmaceutical Consumption Value, 2019 VS 2024 VS 2030, US$ Million

Table 19. By Region, Global Peptide CDMO Pharmaceutical Consumption Value, 2019-2030, US$ Million

Table 20. By Country, Global Peptide CDMO Pharmaceutical Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 21. By Country, Global Peptide CDMO Pharmaceutical Consumption Value, 2019-2030, US$ Million

Table 22. By Country, Global Peptide CDMO Pharmaceutical Consumption Value Market Share, 2019-2030

Table 23. Ambiopharm Company Information, Head Office, Market Area and Industry Position

Table 24. Ambiopharm Company Profile and Main Business

Table 25. Ambiopharm Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 26. Ambiopharm Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 27. Ambiopharm Recent Developments

Table 28. Auspep Company Information, Head Office, Market Area and Industry Position

Table 29. Auspep Company Profile and Main Business

Table 30. Auspep Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 31. Auspep Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 32. Auspep Recent Developments

Table 33. Bachem Company Information, Head Office, Market Area and Industry Position

Table 34. Bachem Company Profile and Main Business

Table 35. Bachem Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 36. Bachem Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 37. Bachem Recent Developments

Table 38. Bcn Peptide Company Information, Head Office, Market Area and Industry Position

Table 39. Bcn Peptide Company Profile and Main Business

Table 40. Bcn Peptide Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 41. Bcn Peptide Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 42. Bcn Peptide Recent Developments

Table 43. Cpc Scientific Company Information, Head Office, Market Area and Industry Position

Table 44. Cpc Scientific Company Profile and Main Business

Table 45. Cpc Scientific Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 46. Cpc Scientific Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 47. Cpc Scientific Recent Developments

Table 48. Creative Peptides Company Information, Head Office, Market Area and Industry Position

Table 49. Creative Peptides Company Profile and Main Business

Table 50. Creative Peptides Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 51. Creative Peptides Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 52. Creative Peptides Recent Developments

Table 53. Chinese Peptide Company Information, Head Office, Market Area and Industry Position

Table 54. Chinese Peptide Company Profile and Main Business

Table 55. Chinese Peptide Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 56. Chinese Peptide Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 57. Chinese Peptide Recent Developments

Table 58. Csbio Company Information, Head Office, Market Area and Industry Position

Table 59. Csbio Company Profile and Main Business

Table 60. Csbio Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 61. Csbio Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 62. Csbio Recent Developments

Table 63. Corden Pharma Company Information, Head Office, Market Area and Industry Position

Table 64. Corden Pharma Company Profile and Main Business

Table 65. Corden Pharma Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 66. Corden Pharma Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 67. Corden Pharma Recent Developments

Table 68. Polypeptide Company Information, Head Office, Market Area and Industry Position

Table 69. Polypeptide Company Profile and Main Business

Table 70. Polypeptide Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 71. Polypeptide Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 72. Polypeptide Recent Developments

Table 73. Hybio Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 74. Hybio Pharmaceutical Company Profile and Main Business

Table 75. Hybio Pharmaceutical Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 76. Hybio Pharmaceutical Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 77. Hybio Pharmaceutical Recent Developments

Table 78. Peptide Institute Company Information, Head Office, Market Area and Industry Position

Table 79. Peptide Institute Company Profile and Main Business

Table 80. Peptide Institute Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 81. Peptide Institute Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 82. Peptide Institute Recent Developments

Table 83. Pepscan Company Information, Head Office, Market Area and Industry Position

Table 84. Pepscan Company Profile and Main Business

Table 85. Pepscan Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 86. Pepscan Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 87. Pepscan Recent Developments

Table 88. Almac Company Information, Head Office, Market Area and Industry Position

Table 89. Almac Company Profile and Main Business

Table 90. Almac Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 91. Almac Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 92. Almac Recent Developments

Table 93. Vivitide Company Information, Head Office, Market Area and Industry Position

Table 94. Vivitide Company Profile and Main Business

Table 95. Vivitide Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 96. Vivitide Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 97. Vivitide Recent Developments

Table 98. Creosalus Inc Company Information, Head Office, Market Area and Industry Position

Table 99. Creosalus Inc Company Profile and Main Business

Table 100. Creosalus Inc Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 101. Creosalus Inc Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 102. Creosalus Inc Recent Developments

Table 103. Scinopharm Company Information, Head Office, Market Area and Industry Position

Table 104. Scinopharm Company Profile and Main Business

Table 105. Scinopharm Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 106. Scinopharm Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 107. Scinopharm Recent Developments

Table 108. Senn Chemicals Company Information, Head Office, Market Area and Industry Position

Table 109. Senn Chemicals Company Profile and Main Business

Table 110. Senn Chemicals Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 111. Senn Chemicals Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 112. Senn Chemicals Recent Developments

Table 113. Belyntic Company Information, Head Office, Market Area and Industry Position

Table 114. Belyntic Company Profile and Main Business

Table 115. Belyntic Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 116. Belyntic Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 117. Belyntic Recent Developments

Table 118. Ferring Pharma Company Information, Head Office, Market Area and Industry Position

Table 119. Ferring Pharma Company Profile and Main Business

Table 120. Ferring Pharma Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 121. Ferring Pharma Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 122. Ferring Pharma Recent Developments

Table 123. Numaferm Peptide CDMO Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 124. Numaferm Company Profile and Main Business

Table 125. Numaferm Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 126. Numaferm Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 127. Numaferm Recent Developments

Table 128. Hybio Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 129. Hybio Pharmaceutical Company Profile and Main Business

Table 130. Hybio Pharmaceutical Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 131. Hybio Pharmaceutical Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 132. Hybio Pharmaceutical Recent Developments

Table 133. Provepharm Life Solutions Company Information, Head Office, Market Area and Industry Position

Table 134. Provepharm Life Solutions Company Profile and Main Business

Table 135. Provepharm Life Solutions Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 136. Provepharm Life Solutions Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 137. Provepharm Life Solutions Recent Developments

Table 138. Enzene Biosciences Company Information, Head Office, Market Area and Industry Position

Table 139. Enzene Biosciences Company Profile and Main Business

Table 140. Enzene Biosciences Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 141. Enzene Biosciences Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 142. Enzene Biosciences Recent Developments

Table 143. Piramal Pharma Company Information, Head Office, Market Area and Industry Position

Table 144. Piramal Pharma Company Profile and Main Business

Table 145. Piramal Pharma Peptide CDMO Pharmaceutical Models, Specifications, and Application

Table 146. Piramal Pharma Peptide CDMO Pharmaceutical Revenue and Gross Margin, US$ Million, 2019-2024

Table 147. Piramal Pharma Recent Developments

List of Figures

Figure 1. Peptide CDMO Pharmaceutical Picture

Figure 2. Global Peptide CDMO Pharmaceutical Consumption Value, (US$ million) & (2019-2030)

Figure 3. China Peptide CDMO Pharmaceutical Consumption Value, (US$ million) & (2019-2030)

Figure 4. By Consumption Value, China Peptide CDMO Pharmaceutical Market Share of Global, 2019-2030

Figure 5. Global Peptide CDMO Pharmaceutical Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 6. China Peptide CDMO Pharmaceutical Key Participants, Market Share, 2022

Figure 7. Peptide CDMO Pharmaceutical Industry Chain

Figure 8. Peptide CDMO Pharmaceutical Procurement Model

Figure 9. Peptide CDMO Pharmaceutical Sales Model

Figure 10. Peptide CDMO Pharmaceutical Sales Channels, Direct Sales, and Distribution

Figure 11. Liquid-phase Peptide Synthesis（LPPS）

Figure 12. Solid-phase Peptide Synthesis（SPPS）

Figure 13. Mixed Phase

Figure 14. By Type, Global Peptide CDMO Pharmaceutical Consumption Value, 2019-2030, US$ Million

Figure 15. By Type, Global Peptide CDMO Pharmaceutical Consumption Value Market Share, 2019-2030

Figure 16. Peptide Supplements

Figure 17. Peptide Vaccines

Figure 18. Others

Figure 19. By Application, Global Peptide CDMO Pharmaceutical Consumption Value, 2019-2030, US$ Million

Figure 20. By Application, Global Peptide CDMO Pharmaceutical Consumption Value Market Share, 2019-2030

Figure 21. By Region, Global Peptide CDMO Pharmaceutical Consumption Value Market Share, 2019-2030

Figure 22. North America Peptide CDMO Pharmaceutical Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 23. By Country, North America Peptide CDMO Pharmaceutical Consumption Value Market Share, 2022

Figure 24. Europe Peptide CDMO Pharmaceutical Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 25. By Country, Europe Peptide CDMO Pharmaceutical Consumption Value Market Share, 2022

Figure 26. Asia Pacific Peptide CDMO Pharmaceutical Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 27. By Country/Region, Asia Pacific Peptide CDMO Pharmaceutical Consumption Value Market Share, 2022

Figure 28. South America Peptide CDMO Pharmaceutical Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 29. By Country, South America Peptide CDMO Pharmaceutical Consumption Value Market Share, 2022

Figure 30. Middle East & Africa Peptide CDMO Pharmaceutical Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 31. U.S. Peptide CDMO Pharmaceutical Consumption Value, 2019-2030, US$ Million

Figure 32. By Type, U.S. Peptide CDMO Pharmaceutical Consumption Value Market Share, 2022 VS 2029

Figure 33. By Application, U.S. Peptide CDMO Pharmaceutical Consumption Value Market Share, 2022 VS 2029

Figure 34. Europe Peptide CDMO Pharmaceutical Consumption Value, 2019-2030, US$ Million

Figure 35. By Type, Europe Peptide CDMO Pharmaceutical Consumption Value Market Share, 2022 VS 2029

Figure 36. By Application, Europe Peptide CDMO Pharmaceutical Consumption Value Market Share, 2022 VS 2029

Figure 37. China Peptide CDMO Pharmaceutical Consumption Value, 2019-2030, US$ Million

Figure 38. By Type, China Peptide CDMO Pharmaceutical Consumption Value Market Share, 2022 VS 2029

Figure 39. By Application, China Peptide CDMO Pharmaceutical Consumption Value Market Share, 2022 VS 2029

Figure 40. Japan Peptide CDMO Pharmaceutical Consumption Value, 2019-2030, US$ Million

Figure 41. By Type, Japan Peptide CDMO Pharmaceutical Consumption Value Market Share, 2022 VS 2029

Figure 42. By Application, Japan Peptide CDMO Pharmaceutical Consumption Value Market Share, 2022 VS 2029

Figure 43. South Korea Peptide CDMO Pharmaceutical Consumption Value, 2019-2030, US$ Million

Figure 44. By Type, South Korea Peptide CDMO Pharmaceutical Consumption Value Market Share, 2022 VS 2029

Figure 45. By Application, South Korea Peptide CDMO Pharmaceutical Consumption Value Market Share, 2022 VS 2029

Figure 46. Southeast Asia Peptide CDMO Pharmaceutical Consumption Value, 2019-2030, US$ Million

Figure 47. By Type, Southeast Asia Peptide CDMO Pharmaceutical Consumption Value Market Share, 2022 VS 2029

Figure 48. By Application, Southeast Asia Peptide CDMO Pharmaceutical Consumption Value Market Share, 2022 VS 2029

Figure 49. India Peptide CDMO Pharmaceutical Consumption Value, 2019-2030, US$ Million

Figure 50. By Type, India Peptide CDMO Pharmaceutical Consumption Value Market Share, 2022 VS 2029

Figure 51. By Application, India Peptide CDMO Pharmaceutical Consumption Value Market Share, 2022 VS 2029

Figure 52. Middle East & Africa Peptide CDMO Pharmaceutical Consumption Value, 2019-2030, US$ Million

Figure 53. By Type, Middle East & Africa Peptide CDMO Pharmaceutical Consumption Value Market Share, 2022 VS 2029

Figure 54. By Application, Middle East & Africa Peptide CDMO Pharmaceutical Consumption Value Market Share, 2022 VS 2029

Figure 55. Research Methodology

Figure 56. Breakdown of Primary Interviews

Figure 57. Bottom-up and Top-down Approaches

Figure 58. Top-down Approaches